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ABSTRACT
Bone is composed of a complex mixture of many dynamic cell types. Flow cytometry and in vivo lineage tracing have offered early
progress toward deconvoluting this heterogeneous mixture of cells into functionally well‐defined populations suitable for further
studies. Single‐cell sequencing is poised as a key complementary technique to better understand the cellular basis of bone
metabolism and development. However, single‐cell sequencing approaches still have important limitations, including
transcriptional effects of cell isolation and sparse sampling of the transcriptome, that must be considered during experimental
design and analysis to harness the power of this approach. Accounting for these limitations requires a deep knowledge of the
tissue under study. Therefore, with the emergence of accessible tools for conducting and analyzing single‐cell RNA sequencing
(scRNA‐seq) experiments, bone biologists will be ideal leaders in the application of scRNA‐seq to the skeleton. Here we provide an
overview of the steps involved with a single‐cell sequencing analysis of bone, focusing on practical considerations needed for a
successful study. © 2019 American Society for Bone and Mineral Research.
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Introduction
Howmany discrete populations of mesenchymal cells exist inbone? What is the differentiation hierarchy among these
populations, and is this linear or more complex and plastic? How
do external stimuli shape the dynamics of these populations to
impact bone formation? Understanding the cellular basis of
bone formation requires clarity on each of these points and is
therefore among the highest priorities for skeletal biology.
However, for many years, progress on these issues has been
hampered by limitations inherent in traditional methods to
identify, isolate, or otherwise study skeletal cells, which produce
highly heterogeneous pools containing many mesenchymal cell
types. For example, traditional bone marrow stromal or calvarial
osteoblast cultures are typically composed of an extremely
heterogeneous mixture of cells.(1) This leads to an inability to
assign phenotypes observed in vitro to discrete cell populations,
and changes in cellular composition either between experi-
mental and control groups or over the course of the culture
experiment may confound experimental interpretation. More-
over, unappreciated differences in the cellular composition of
heterogeneous skeletal mesenchymal cultures are likely to be a
major contributor to problems with experimental reproducibility
among labs.(2) Some of these issues potentially extend to in vivo
studies using single markers to identify populations of interest,
as many available markers capture not one but multiple cell
populations.(3,4) In addition to these methodological factors that
confound progress in understanding the cellular basis of bone
formation, mesenchymal biology has inherent features that
make resolving discrete populations of mesenchymal cells and
determining their hierarchy challenging. Mesenchymal cells are
notorious for displaying a high degree of plasticity and
phenotypic instability in culture that complicate in vitro analysis
of skeletal populations. Examples of this include the propensity
of chondrocyte cultures to dedifferentiate in culture, the high
degree of plasticity displayed by mesenchymal cells relative to
other tissues, and the inability of some populations to survive in
vitro in the absence of stimulation.(5–7)
To solve this issue of heterogeneity confounding our
understanding of the cellular composition of bone, examina-
tion of other fields that have addressed similar questions can
suggest successful strategies. In particular, immunology has
identified an extensive range of discrete cell types and has
assigned functions and molecular identities to each of
these populations.(8,9) Perhaps the major factor facilitating
this success has been an early adoption of single‐cell
analyses throughout the field, in this case predominantly flow
cytometry, that allowed for identification and subsequent study
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of discrete cellular populations.(10) Thus, single‐cell approaches,
when used in concert with supporting in vivo and ex vivo
functional studies, are likely to be key in facilitating skeletal
biology to reach a similarly detailed understanding of the
cellular compartment of our organ of interest. However, efforts
to adapt these approaches to the particular challenges of bone,
including issues related to cellular isolation of bone cells, will
be needed.
Although flow cytometry remains an indispensable tech-
nique because of its ability to prospectively isolate defined
cellular populations for further study, complementary ap-
proaches in the form of single‐cell RNA sequencing (scRNA‐
seq) have flourished over approximately the past 5 years. Over
this time, scRNA‐seq has moved from being a technique
restricted to a handful of technology‐focused research groups
to becoming a truly “ready for prime time” approach that is
accessible to a wide range of investigators primarily focusing
on biological questions and not methodology. The increasing
availability of powerful single‐cell technologies offers an
unprecedented ability to deconvolute mixed populations of
cells and identify new discrete cellular populations contributing
to bone physiology. As an example of this promise, scRNA‐seq
studies of lung tissue have identified a novel cell type that is
the major cell expressing the CFTR channel in airway
epithelium, demonstrating the ability of scRNA‐seq to provide
substantial insights into the cellular basis of physiology and
disease.(11,12) At the same time, these technologies still have
important limitations as discussed below that must be taken
into account. Here, we aim to provide a practical overview of
application of this family of technologies to skeletal biology,
including suggestions for investigators who are looking to add
single‐cell sequencing to their experimental toolbox.
Planning a scRNA‐seq Study of Bone
Although single‐cell RNA‐seq technologies are constantly
evolving, two classes of approaches to capturing single cells
have become available: 1) methods that rely on index sorting
by FACS to achieve single‐cell capture, and 2) techniques that
utilize microfluidics‐based capture of cells into droplets in an
emulsion (Fig. 1, Table 1). The initially emerging index‐based
techniques (also known as Smart‐seq) rely on sorting single
cells into individual wells of 96‐ or 384‐well plates and
processing their transcriptomes into RNA‐seq libraries while
they are physically separated.(13,14) This method allows the
sequencing of entire transcripts; however, the per cell cost of
this technique tends to be considerably higher than that of
microfluidics‐based methods and scaling to large total num-
bers of captured cells can be limited by sorting rate. Other
index sorting methods include MARS‐seq and CEL‐seq/CEL‐
seq2.(15–17) Index sorting methods are therefore advantageous
in “deep‐sequencing” experiments, wherein the aim is to
characterize the individual transcriptomes of a small group of
cells thoroughly, rather than interrogating the diversity of a
highly heterogeneous pool of cells and identifying rare
populations. Conversely, recently developed droplet/microflui-
dics‐based methods, including Drop‐seq, inDrop, and the
commercial 10× Genomics platform, allow large numbers of
cells (10,000 to 100,000) to be captured and processed in a
rapid fashion.(18–20) Briefly, single cells are captured inside
aqueous droplets emulsified in oil with beads ligated to
cell‐indexing primers. The cell membrane and nucleus are lysed
to release the mRNA from each cell to mark each of its
transcripts with a unique barcode (also known as unique
molecular identifier, or UMI). These barcodes are later utilized in
verifying the uniqueness of each mRNA molecule and thereby
eliminate bias associated with repeat sampling of transcripts
that are highly amplified during library preparation. An
additional droplet‐specific barcode separates the collective
sequence output into cell‐specific bins. Droplet‐based methods
have gained tremendous popularity since they were pioneered
in 2015,(19,20) as they allow convenient processing of tens of
thousands of cells and can therefore quantify the cellular
heterogeneity of highly complex tissues, such as the retina or
bone marrow, while facilitating the discovery of previously
unrecognized cell populations. However, unlike the SMART‐seq
method, current droplet‐based single‐cell RNA‐seq relies on 3ʹ
biased sequencing of each mRNA molecule. Furthermore, while
all current scRNA‐seq methods are limited to largely capturing
only a fraction of highly expressed mRNAs from each cell, Drop‐
seq captures fewer transcripts per cell than Smart‐seq, which
can exacerbate analytic challenges created by sparse tran-
scriptome sampling. Detailed analysis of the relative strengths
of specific methods is available in recent methodologic
comparison studies.(18,21)
The per cell sequencing depth is an important experimental
design parameter largely determined by the scRNA‐seq method
utilized. Earlier single‐cell RNA‐seq studies in the field of
neuroscience suggest that 50,000 or even fewer reads per cell
might be sufficient to define distinct cell populations.(22,23) The
aforementioned sequencing depth might be expected to lead to
the detection of 1000 to 3000 genes per cell population. However,
the definition of this minimum threshold needed for robust
separation of cellular populations is highly dependent on the
complexity of the tissue at hand, as well as the objective of the
experiment; much deeper sequencing may be necessary for data
saturation to detect rare cell types. Additionally, it should be
noted that estimates suggest that a mammalian cell expresses
approximately 12,000 genes across 100,000 or more mRNA
molecules, which suggests that most scRNA‐seq methods are
capable of sampling only a fraction of the total transcriptome, and
this fraction is weighted toward genes with the highest
expression. This poses a challenge for scRNA‐seq to monitor
transcriptional response or classify cell types in a sample, as many
genes of interest, including cell type–defining transcription
factors, show lower degrees of expression. The deeper transcrip-
tome sampling offered by bulk RNA‐sequencing on purified cell
types can aid in overcoming this challenge when used in parallel.
Bulk RNA sequencing can be particularly useful for discovery of
genes of interest that can then be queried in scRNA‐seq data sets.
Thus, scRNA‐seq and bulk RNA sequencing should be viewed as
complementary rather than competing techniques.
In addition to choosing a suitable scRNA‐seq method, another
key step in planning a scRNA‐seq experiment is to consider
exactly which cells will be submitted for sequencing, which
subset of cells within this population represent the population of
interest, and how these cells will be isolated. Consideration of
these points is needed to ensure that the population of interest
will be sufficiently represented to allow for robust downstream
analysis. Wherever feasible, performing scRNA‐seq on cells
isolated directly from bone without intervening culture is
advised, as certain stem cell and progenitor populations may
be lost upon culture, even when “basal” culture conditions are
utilized.(3) An important decision when planning the cell
isolation is whether cells will be subjected to FACS before
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Fig. 1. Techniques for single‐cell isolation and library generation. (A) Limiting dilution method to isolate single cells. (B) Laser capture microdissection
(LCM) to isolate single cells from biological samples. (C) FACS‐based isolation of specific cell types based on fluorescent marker proteins. (D) Microfluidic
technology for capturing single cells as used in Drop‐seq and other methods. Drop‐seq allows transcriptional profiling of thousands of single cells by
encapsulating cells in nanoliter droplets along with uniquely barcoding beads. It reveals transcriptionally distinct cell populations present in complex
biological tissue creating a molecular atlas of gene expression. (E) A schematic representation of droplet‐based library preparation. Individual cells are
captured into droplets with microparticles that contain barcoded primers (beads). The primers on all beads contain a common sequence (PCR handle) for
PCR amplification, cell barcode, and different unique molecular identifiers (UMIs) that allow mRNA transcripts to be digitally counted. Cells are lysed and
the mRNAs are reverse transcribed into cDNAs, creating a set of beads called single‐cell transcriptomes attached to microparticles (STAMPs) followed by
cDNA amplification. Template switching is used to introduce a PCR handle downstream of the synthesized cDNA. (F) Schematic representation of single‐
cell combinatorial‐indexing RNA‐sequencing analysis 3 (sci‐RNA‐seq3). The technique involves a combinatorial indexing method that labels
transcriptomes of single cell or nuclei. Nuclei from fresh tissue sample are extracted and fixed. A molecular index is applied to the mRNA from each cell
followed by in situ reverse transcription incorporating a barcode bearing a polythymidine primer with a UMI. Cells are pooled and redistributed. For sci‐
RNA‐seq3, hairpin ligation is performed for the third level of indexing. PCR primers target the barcoded polythymidine primer resulting in PCR amplicons
to capture the 3ʹ ends of transcripts and these primers introduce a second barcode specific to each well of the PCR plate. Amplicons are pooled and
sequenced, creating a 3ʹ ‐tag digital gene expression profile. [Color figure can be viewed at wileyonlinelibrary.com]
single‐cell sequencing or if cells will be directly utilized after
enzymatic digestion. FACS has the advantage of clearing
doublets, dead cells, and debris from the sample, and FACS
allows for direct assessment of population frequencies present in
the specimen, which can provide a key reference point to guide
setting parameters during later analysis. FACS can also facilitate
restricting the cells sequenced to only a small group of interest,
thereby increasing the relative representation of these groups
and avoiding expense associated with sequencing large
numbers of cells not relevant to the study. This can be critical
for bone biology, as, without additional enrichment steps,
mesenchymal cells are often outnumbered by hematopoietic
cells in most specimen types. Hematopoietic depletion strategies
include negative selection on the pan‐hematopoietic marker
CD45 (gene symbol PTPRC), though due to the weak expression
of CD45 on certain erythroid lineage cells additional negative
selection with erythroid markers such as CD71 (transferrin
receptor, gene symbol TFRC), glycophorin A (CD235a, gene
symbol GYPA), or Ter119, a mouse‐specific antibody clone
recognizing Ly76, may be necessary for comprehensive removal
of hematopoietic cells.(24) Endothelial cells can be depleted
based on negative selection on the pan‐endothelial marker
CD31 (gene symbol PECAM1). Notably, capture of some number
of unwanted cell populations is inevitable even with FACS and
these cells must be accounted for during analysis.(3,25) Addition-
ally, use of cell type–specific fluorescent reporters, such as a GFP
variant driven by a reporter active in osteoblasts or cre‐based
lineage tracing methods, can allow for positive selection of
populations of interest.
When an index sorting method is employed, the surface
immunophenotype of each cell can be linked with that
particular cell’s transcriptome. This linking of surface immuno-
phenotype to transcriptome is a key advantage, as it offers a
solution to perhaps the biggest drawback of scRNA‐seq studies:
the inability to prospectively isolate populations of interest
identified in these studies. Without prospective isolation of
populations discovered with scRNA‐seq, this approach is largely
limited to being descriptive, as no functional studies can be
performed. This limitation stems from the transcripts defining a
population of interest rarely being either cell surface markers
suitable for FACS or having an associated genetic reporter.
Linked flow cytometry and transcriptome data can identify the
surface immunophenotype corresponding to a cluster of
interest, allowing for prospective isolation of this population
in subsequent experiments. Notably, staining cells with
antibodies containing nucleic acid barcodes as in the CITE‐
seq technique or the commercial version, TotalSeq, may allow
for similar advantages as index sorting methods in terms of
linking surface immunophenotype to cell clusters of interest.(26)
Disadvantages of adding a pre‐sequencing FACS step include
the additional time and experimental complexity added.
Additionally, FACS itself can have a negative effect on cell
viability, though optimization of nozzle sizes and flow rates can
minimize these effects; a larger nozzle size with a slower flow
rate generally offers a better outcome.(3) Regardless of whether
FACS is used, optimization of enzymatic digestion conditions
for cell viability and yield is critical, as in our experience this
represents the most common point of experimental failure in
scRNA‐seq studies. In keeping with this, comparison of in vivo
transcriptional profiles on fixed cells to cells undergoing a
typical isolation protocol in muscle suggests that enzymatic
digestion is the major step that can disrupt the in vivo
transcriptional profile.(27) This emphasizes the importance of
minimizing the duration and harshness of enzymatic digestion,
and we note that brief digestion protocols can provide robust
yields of mesenchymal cells, particularly in younger mice.(3)
Alternatively, there are several approaches designed to
circumvent isolation‐associated artifacts, including in vivo
fixation before cell isolation, though fixation can negatively
impact cell isolation efficiency and RNA quality.(27,28) In another
approach, transgenic expression of Toxoplasma gondii uracil
phosphoribosyltransferase (UPRT) only in cell types of interest
allows for selective labeling, capture, and bulk sequencing of
transcripts only from this cell type after whole‐tissue RNA
extraction.(28) However, this method requires a suitably specific
promoter that allows targeting UPRT expression only to the cell
type of interest, and experience to date with cre lines suggests
that such a promoter may be elusive in the skeletal system.
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Table 1. A Comparison of scRNA Sequencing Methods
Methods Region UMI System of isolation
cDNA
amplification Library construction
No. of genes
detected/
cell Cost ($)/cell
MARS seq (2014) 3ʹ end Yes, 8 bp UMI FACS IVT RNA fragmentation;
adaptor ligation
4763 lowest
sensitivity
~1.3
SCRB seq (2014) 3ʹ end Yes, 10 bp UMI FACS PCR Tagmentation; 3ʹ
enrichment
7906 ~2
Smart‐seq/C1 (2014) Full length None Fluidigm C1 PCR Tagmentation 7572 ~25
Smart‐seq2
(2013, 2014)
Full length None FACS PCR Tagmentation 9138
highest
sensitivity
~30
(commercial)
Drop seq
(2015)
3ʹ end Yes, 8 bp UMI Droplets PCR Tagmentation; 3ʹ
enrichment
4811 lowest
sensitivity
~0.1
inDrop Seq
(2015)
3ʹ end Yes, 6 bp UMI Hydrogel‐based
droplets
IVT RNA fragmentation;
reverse transcription
— ~0.06
CEL‐seq2/C1
(2016)
3ʹ end Yes, 5 bp UMI Fluidigm C1 IVT RNA fragmentation;
reverse transcription
7536 ~9
UMI= unique molecular identifier; FACS= fluorescence activated cell sorting; IVT= in vitro transcription; PCR= polymerase chain reaction.
Summary parameters for the listed scRNA‐seq methods are provided. Date of publication is indicated. Cost per cell is in US dollars. Tagmentation is a
library preparation reaction, in which a transposase cuts a double‐stranded DNA and inserts the linker sequences required for sequencing.
Recent work on muscle comparing post‐isolation to “in vivo”
transcriptional profiles provides insight into the likely scope
and degree of the impact of tissue digestion and isolation;
these procedures induce an immediate early stress response
and loss of quiescence that may occur predominantly in
subpopulations of cells.(27–29) Particular care is warranted in
assessing whether such isolation‐associated activating tran-
scriptional changes may either drive cell clustering or confound
efforts to assess the transcriptional response to environmental
or genetic perturbations.
In addition to the isolation procedure potentially influencing
the transcriptome, some types of bone cells of high importance,
such as osteocytes, can be challenging to dissociate into single‐
cell suspension, though there are examples of success.(30,31)
Similarly, some large cell types, such as mature multinucleated
osteoclasts may become physically disrupted or otherwise lost
during FACS or microfluidics steps. Thus, all cellular isolation
methods will necessarily introduce bias in the frequencies of cell
types present relative to the in vivo tissue, with some cell types
underrepresented or absent. These biases will largely be
determined by the enzymatic digestion protocol employed.
For these cell types with challenging isolation requirements,
epigenetic readouts such as single‐cell ATAC‐seq may offer a
more stable method to assess cell state in the face of harsh
isolation procedures and can be multiplexed with scRNA‐seq
using recent methods, though it is noted that epigenetic
features can also be impacted by cell isolation protocols.(27,32,33)
The field of neuroscience in particular has had to deal with
challenges in disassociating their tissue of interest into a single‐
cell suspension and has found success in instead performing
sequencing of single nuclei through a family of microfluidics
or flow cytometry–based approaches.(34–37) Because these nuclei
are generally easier to isolate than intact cells and many of these
methods can be used on fixed tissue, single nuclear sequencing
methods may have utility in allowing robust analysis of
particularly hard to isolate populations such as osteocytes.
We note that recent advances employing a combinatorial
barcoding labeling of nuclei have resulted in methods, such as
Sci‐RNA‐Seq3, displaying very high throughput and favorable
per cell sequencing costs.(38,39)
Before starting sequencing, a validation step is needed to
ensure that single cells are being captured by the methodology
employed. To clarify terminology relevant to this validation, most
scRNA‐seq methods have a proxy term to refer to individual cells
in the analysis, as the occurrence of either cellular doublets or
beads/wells containing only free‐floating “background” RNAs and
no cells break the expectation that each data point represents one
cell. These cell equivalent terms include “STAMPs” (single‐cell
transcriptomes attached to microparticles) for microfluidics
particle capture–based methods such as drop‐seq or just “wells”
for index sorting–based methods.(20) For all methods, validation of
the doublet rate and cell capture rate is essential. For index
sorting methods, this is fairly straightforward and consists of a test
sort where each well is examined visually after sorting, primarily to
assess the rate of empty wells, as the use of doublet gates makes
issues with post‐sort doublets rare. For microfluidics/droplet‐
based methods, this commonly takes the form of a species mixing
experiment, where typically human and mouse cells are mixed
together at different numbers and the rate of STAMPs containing
transcripts from both species is assessed.(20) Higher‐input numbers
result in capture of larger numbers of STAMPs but result in higher
doublet rates, and these two factors need to be balanced in pre‐
experimental validation.
Lastly, the limitations inherent in scRNA‐seq approaches
suggest that this technique is best reserved for questions
specifically requiring this approach and that robust considera-
tion of alternatives is warranted. For instance, examination of
gene expression signatures or transcriptional responses to
genetic or environmental perturbations in known populations
of defined, isolatable cell types would be best accomplished by
bulk RNA‐sequencing rather than scRNA‐seq. Additionally,
similar to the gene expression atlases built with bulk RNA‐
sequencing, tissue atlases utilizing single‐cell sequencing of
large numbers of cells have recently become available and
often include analysis of skeletal mesenchyme.(40–42) As these
resources continue to expand, they may offer a route to answer
selected questions utilizing existing data, especially for ques-
tions focusing on basal identity and gene expression in skeletal
cells in the absence of specific stimuli.
Analysis of scRNA‐seq Data From
Skeletal Specimens
Perhaps the step that requires the greatest effort in a scRNA‐
seq experiment is not cell isolation or sequencing but rather
data analysis. Fortunately, scRNA‐seq analysis approaches have
been evolving at least as rapidly as the sequencing methods
themselves, leading to a wide range of options, which notably
include several very accessible tools that facilitate bone
biologists with no prior computational training to conduct
this analysis themselves(43–45) (Table 2). Regardless of the
software used, the analysis process typically involves four key
steps: approaches to account for technical artifacts/data
cleaning, dimensionality reduction, clustering, and post‐clus-
tering examination of gene expression (Fig. 2). To summarize
each of these in order, scRNA‐seq is subject to characteristic
confounding by covariates that must be addressed during the
early stages of analysis. These include batch effects, the relative
content of mitochondrial and ribosomal RNA, the total number
of transcripts collected from each cell equivalent, or the cell
cycle stage of each cell. Often, the effects of these covariates
can be large relative to the biologic variation of interest,
necessitating understanding and subsequently addressing their
impact. Methods to address these include filtering out outlier
cells, downsampling of populations with higher per cell
transcriptional sampling than the rest of the specimen, or
regression to remove the portion of the signal driven by these
covariates. However, the impact of “regressing out” these
covariates should be carefully and manually assessed in the
final analysis, as some of these covariates may be unequally
present in cell clusters of interest, leading to regression
potentially masking the true biologic signal associated with
these populations. It is worth emphasizing that this and nearly
every other step of this analysis process will be ideally subject
to iterative tweaking of analysis parameters and observing
whether these tweaks help to recapitulate expected biology
present in the sample. In this respect, scRNA‐seq analysis is
intensely informed by one’s knowledge of the relevant under-
lying biology and is best conducted by investigators with a
deep familiarity with this biology, though support of institu-
tional cores and consulting bioinformaticians can be critical.
Next, most analysis platforms engage in some kind of
dimensionality reduction and clustering. Dimensionality reduc-
tion often takes the form of principal component analysis
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Table 2. Examples of scRNA‐seq Analysis Pipelines
Pipeline Year Programming language Dimensionality reduction Strategy
Monocle 2014 R ICA, MST Differential expression
SCUBA 2014 Matlab t‐SNE Principle curve
Waterfall 2015 R PCA, k‐means, MST Cell clustering
Wishbone 2016 Python PCA, diffusion maps Ensemble
TSCAN 2016 R PCA MST clusters
StemID 2016 R PCA, ICA Cell clustering
Slingshot 2017 R Any Cluster‐based MST
scTDA 2017 Python Any (MDS, ICA, t‐SNE) Topology‐based differential
expression
Velocyto 2018 R, Python PCA Cell clustering
Monocle 3 2019 R t‐SNE or UMAP Louvain clustering
ICA= independent component analysis; MST=minimal spanning tree; t‐SNE= t distributed stochastic neighbor embedding; PCA= principal
component analysis; MDS=multidimensional scaling; UMAP= uniform manifold approximation and projection.
A number of analysis pipelines focus on inferring the differentiation trajectory of populations present in scRNA‐seq data, including Monocle,(57)
SCUBA,(95) Waterfall,(96) Wishbone,(97) TSCAN,(98) Slingshot,(99) scTDA,(100) and Monocle 3.(40) Velocyto focuses on inferring future gene expression
profiles of each cell via analysis of unspliced transcripts.(56) StemID focuses on identification of rare outlier populations.(55)
Fig. 2. Application of scRNA sequencing to decode biological complexity. (A, B) Single‐cell analysis captures transcriptional profile of individual cells
and can deconvolute populations present in suspension of mixed cell types. Principal component analysis (PCA) is a linear dimensionality reduction
method and can be used to identify different cell clusters present in heterogeneous cell populations (B). t‐SNE (t‐distributed stochastic neighbor
embedding) is a nonlinear dimensionality reduction method commonly used to display different cell clusters. (C) A violin plot is a density plot that can
be used to determine the expression of a gene across different cell clusters. Dots represent individual cells. (D–G) Different types of scRNA analysis
pipelines can infer cell commitment/hierarchy (D), cell trajectory (E), decode gene expression patterns (F), or stem cell differentiation (G). Dots
represent the location of individual cells on the differentiation trajectory. scTDA (single‐cell topological data analysis) is a topology‐based
computational algorithm that can be used to infer cell hierarchy and differentiation. Asynchronized cells represent different instantaneous time points
along cell trajectories. scTDA resolves asynchrony and reconstructs a dynamic, continuous cell trajectory pathway (D). Monocle is an unsupervised
algorithm that infers cellular differentiation trajectories occurring across the time surrogate pseudotime (E). [Color figure can be viewed at
wileyonlinelibrary.com]
(PCA), which simplifies the complex variation present in the
sample by identifying covariant transcripts and grouping these
together in principal components (PCs). For instance, osteo-
calcin (BGLAP) and other transcripts highly expressed in
osteoblasts, such as COL1A1 and bone sialoprotein (IBSP) and
others, may be grouped together, a set of genes called
metagenes, into a principal component reflecting osteoblast
identity. Often, it is instructive to manually examine the genes
comprising each of the PCs to see what aspect of mesenchymal
biology is being captured. Depending on the specimen
preparation method, early PCs will likely be dominated by
the signature of erythroid cells or leukocytes given their broad
differences in gene expression in comparison to skeletal
mesenchyme. Some PCs may largely correspond to the
covariates discussed above, and visualizing these covariates
across the top few principal components can be a helpful
method to understand their impact on downstream analyses.
For instance, cell cycle often drives one or more of the early
PCs, and observing disappearance of this PC can be helpful in
ensuring that regression or other approaches have accounted
for cell cycle effects. After PC generation, users will commonly
select which of these PCs to use to cluster the data using k
means clustering or another method. Computational methods
such as a Jackstraw plot can help illustrate how likely each
principal component is likely to have been observed by chance
and thereby help guide selection of which PCs can aid in
guiding a biologically meaningful clustering of the data.
However, perhaps the most useful method is to iteratively
conduct the analysis with different numbers of PCs and
empirically observe how these choices impact populations of
interest, using populations that correspond to osteoblasts,
chondrocytes, or other clearly delineated mesenchymal popu-
lations as “landmarks” to aid in evaluating how expected
populations segregate as an internal control for the correctness
of the clustering.
The last step in scRNA‐seq analysis is to display the clusters
and understand which cellular populations are represented by
analyzing both the genes defining each cluster and also the
expression of genes of interest that classically define known
populations, such as osteocalcin transcripts defining mature
osteoblasts. Clusters are typically represented using t distrib-
uted stochastic neighbor embedding (t‐SNE), a dimensionality
reduction data visualization algorithm,(46) or more recently,
uniform manifold approximation and projection (UMAP).(47)
Notably, t‐SNE employs several user‐defined parameters that
can have dramatic effects on the end output, meaning that
caution is required to avoid overinterpretation of features such
as cluster size or distance that may reflect these user‐defined
parameters more than the underlying data (https://distill.pub/
2016/misread‐tsne/).(48)
With the ability to characterize the transcriptomes of
individual cells, one intriguing question is whether gene
expression changes in distinct cell populations can be detected
after pharmacologic, genetic, or environmental perturbations
on the skeleton. Although this is an exciting possibility, there
are multiple important challenges to consider before at-
tempting comparative gene expression profiling experiments
with scRNA‐seq. First, currently available methodologies
capture only a small percentage of the transcripts (roughly
5% to 15%) present in each cell. As a result of this sparse and
stochastic sampling, gene expression data may be difficult to
interpret for genes with mid to low expression levels, as many
of these genes may show apparent “dropout” of expression of
these transcripts within each cluster due to that transcript not
being sampled in that particular cell. As a result, the apparent
absence of a gene of interest in a cluster must be interpreted
with caution, as it may simply represent that the transcript is
expressed at a level below the high threshold needed for
detection. These issues can be further complicated if differ-
ences in transcript sampling among cellular populations lead to
different detection thresholds in each cluster. Computational
strategies to address this issue include MAGIC (Markov affinity‐
based graph imputation of cells), which infers values for gene
expression data missing due to sampling issues in each cell
based on gene expression in similar cells.(49) Alternatively,
where feasible, cellular isolation followed by bulk RNA‐
sequencing offers perhaps the most straightforward method
to experimentally validate gene expression changes observed
by scRNA‐seq. Second, an equally important consideration is to
ensure proper definition of distinct clusters that accurately
represent the cellular diversity of skeletal tissues at hand: As
they descend from similar lineages and exhibit functional
similarities, distinct mesenchymal cell populations co‐express
several genes at high levels, and their transcriptomes in a
single‐cell RNA‐seq data set can resemble each other, leading
to coclustering of very distinct cell populations. Therefore, a
thorough evaluation of each cell cluster in order to exclude
methodological artifacts is essential during data analysis.
Recently developed feature‐barcoding techniques such as
CITE‐seq and TotalSeq show little dropout and can help
overcome this issue and verify cell identity through correlation
of membrane‐bound protein markers and transcriptional
output.(26) A third and perhaps more obvious challenge is to
ensure that the transcriptomes of cells are not significantly
altered by the cell isolation process. Although there have been
concerns that FACS can perturb gene expression, published
validation studies in non‐bone tissues show minimal effects on
gene expression with optimized protocols.(50–52) As also
discussed above, cell isolation–induced biases or artifacts can
be particularly difficult to exclude when the goal of the
experiment is to characterize the effects of environmental
changes (such as dietary intake or mechanical loading) in the
absence of an internal control (such as a genetic mutation
blocking this response).
Despite the potential complexity of the scRNA‐seq analysis
pipeline, an increasing number of software tools are available,
and several of these are designed to be accessible to
investigators with no prior computational biology training.
Notably, Seurat has online tutorials designed to get new users
started with scRNA‐seq analysis (https://satijalab.org/seurat/)
and has several tools to help with regression or filtering‐based
approaches to account for covariates.(53) In addition to the
basic analysis pipeline described here, a number of analytic
tools have been designed to focus on answering specialized
questions (Table 2). One of these, RaceID, focuses on
identifying outlier cells relative to each of the clusters and
thereby attempts to identify rare, sparsely sampled populations
that may be of biologic interest.(54) Combination of RaceID
approaches with identification of computational features of
stemness, including high transcriptional entropy and inter-
connectedness of the population in an inferred differentiation
trajectory, has been used for de novo computational identifica-
tion of stem cell populations.(55)
Another set of analysis tools focuses on inferring the
relationships among the populations defined during the
clustering step, often by defining a series of edges or lines
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that connect these populations into a tree or trajectory through
additional dimensionality reduction. These connections are
typically inferred on the principle that changes in gene
expression as cells differentiate tend to be parsimonious,
involving minimal changes during each differentiation event.
For example, a series of cells differentiating along an osteoblast
differentiation pathway are likely to retain many elements of
the transcriptional character of osteoblasts during this process
and therefore be more transcriptionally similar to each other
than to unrelated mesenchymal lineages. In a common form of
this analysis, construction of a minimum spanning tree,
algorithms seek to connect all of the cell clusters with a
“tree” that minimizes total sum of the “distances” of these
connections across a space representing gene expression.
Notably these kinds analyses makes the assumption that all of
the cell types present in the sample share a lineage relation-
ship, and for some types of specimens such as those including
both endosteal and periosteal mesenchymal cells, this assump-
tion may be false.(3) Thus, these approaches are greatly
enhanced when used in conjunction with positive selection
for a genetically encoded lineage tracing marker to provide
assurance that the cells under analysis do share a lineage
relationship. In an alternative method to infer cellular
differentiation trajectories, a recent approach measures RNA
velocity, or the rate of change in the expression of a gene
through the ratio of unspliced to mature transcripts.(56) This can
in turn be used to infer the future expression profile of cells and
predict impending transitions among cell types. One of the
most widely used tools for this kind of analysis is
Monocle.(40,57,58) After dimensionality reduction and clustering,
Monocle performs minimum spanning tree analysis to connect
each cell cluster, finds the longest path along this tree, and
then orders these clusters according to an inferred timeline of
differentiation. Because this timeline does not refer to actual
measured time, it is instead termed “pseudotime.” Proof of
concept of this approach includes demonstrating that Monocle
2 can reconstruct known hematopoietic lineage trees from
single‐cell data. Notably, Monocle is able to accept sequential
data drawn from multiple time points, making it particularly
suitable for reconstructing in vitro cellular differentiation
pathways from multiple sampled cultures of asynchronously
differentiating cells or an analysis of the differentiation of cells
in a fracture callus over time.
In scRNA‐seq studies, some tissue types appear to show
robust separation by clustering, such as different lineages of
immune cells, while other tissue types display less robust
separation due to broadly shared gene expression programs,
intermediate cell states, or other causes. Studies to date
suggest that skeletal mesenchyme may fall more in the latter
than the former category, so tools that focus on resolving
closely related populations may be useful in skeletal studies.(3)
One clustering algorithm, biSNE (biclustering on stochastic
neighbor embedding), aims to enforce a more robust separa-
tion of populations and thereby delineate between distinct but
related cell populations and may thereby be useful for
separating distinct mesenchymal subpopulations.(35)
Validating scRNA‐seq Results
As the technical and analytic issues described above can lead to
the identification of spurious cellular populations, validation of
populations identified by scRNA‐seq with a complementary
method should be considered a key component of any
complete scRNA‐seq study. When the genes defining the
cluster of interest include cell‐surface markers, flow cytometry
offers a straightforward validation path. However, clusters may
lack defining cell surface markers, and even when putative
cluster‐defining cell surface markers are identified, suitable
antibody reagents may not be available. Furthermore, the
overall weak correlation between mRNA and protein abun-
dance for many genes may frequently prevent this approach,
resulting in distinct sets of genes serving as the most robust
markers of a given cell type when using RNA versus protein‐
based detection methods.(59,60) An improved interpretation of
scRNA‐seq results in the context of skeletal biology can be
achieved by revealing the spatial identity of the identified cell
populations. This is typically done by testing identified cell
type–specific markers on histological sections. This in situ
corroboration of flow cytometry–based transcriptional profiling
is challenging because of its high technical sensitivity, and
discrepancies between scRNA‐seq and histological analyses are
often encountered. It is important to note that some RNAs and
proteins can significantly lose their integrity and antigenicity,
respectively, during routine histological procedures. A protocol
maintaining tissue samples as much in native conditions as
possible would be ideal. However, it is practically impossible
because of the inherent structural hardness of bone tissues
requiring complex tissue preparations, such as extended
fixation and decalcification. Where relevant, analysis of mini-
mally fixed and decalcified tissue, such as embryonic or
neonatal bones using frozen sections, can help minimize the
impact of these issues.
Major approaches validating expression of identified markers
in an effort to confirm the presence of populations identified by
scRNA‐seq approaches include immunohistochemistry (IHC), in
situ hybridization (ISH), and use of genetically engineered
reporter lines, particularly in knock‐in reporter mice if available.
The success of IHC‐based validation entirely relies on the
quality of antibodies available, and antibodies that work in
other tissues sometimes do not work well on bone sections.
Additional steps are often required, including antigen retrieval
and signal amplification, depending on how tissue samples
have been prepared. Moreover, genes encoding proteins
released into the milieu or the circulation, such as cytokines
and hormones, may have staining patterns irrelevant to their
cellular origin. Considering all these variables, ISH is often a
more straightforward and indeed preferable method to
validate expression of marker genes identified by scRNA‐seq
analyses. Historically, ISH was a technique most widely used for
embryology. However, with the advent of a high‐sensitivity ISH
approach such as RNAscope technology (Advanced Cell
Diagnostics [ACDBio], Newark, CA, USA), its application has
been significantly expanded. This technology utilizes double Z
probes (18~25 bp each, designed up to 20 probes) that
increases the specificity and sensitivity of the hybridization,
followed by explosive amplification of the signal. Probes for the
vast majority of genes are readily available from the supplier.
Although the applicability of ISH has been substantially
expanded, detecting genes that are expressed only at a low
level can still be challenging. It can be particularly the case for
adult bones, due in part to the need for deep decalcification.
The third option, use of transgenic reporter lines widely
available in mice, is indeed a reliable and reproducible way
to validate expression of identified marker genes in situ.
Fluorescent proteins that are stable during complex tissue
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preparations, including eGFP, eYFP, tdTomato, and mCherry,
are used to visualize cells of interest by recapitulating
endogenous gene expression. Typically, a cassette encoding a
fluorescent protein is inserted into the endogenous locus or the
transgene so that its expression is regulated by the promoter
and enhancer of the gene of interest. This transgenic reporter‐
based approach is highly versatile and facilitates downstream
analyses because tagged cells can be readily isolated as live
cells on flow cytometry and cell sorting. A large collection of
transgenic reporter mouse lines are available from the public
repositories, including the Jackson Laboratory (Bar Harbor, ME,
USA; www.jax.org), MMRRC (www.mmrrc.org), and the GENSAT
(www.gensat.org). A combination of these approaches should
be utilized to validate and reveal the anatomic distribution of
cell populations identified by scRNA‐seq analyses.
Spatially Annotated scRNA‐seq Approaches
For bone biologists, the specific location of a given cell within a
complex microenvironment provides important clues as to that
cell’s identity and function. Spatial information also has an
advantage over transcriptional data in that it is not subject to
constant fluctuation due to cellular plasticity or phenomena
such as transcriptional bursting.(61–63) Two cells with an
identical transcriptome may perform discrete functions, de-
pending on their neighboring cells or matrices in which they
are embedded. This critical piece of information is permanently
lost upon cell dissociation, an inevitable step to prepare cells
for above discussed scRNA‐seq procedures. For most investi-
gators, the most straightforward method to annotate the
anatomic location of cellular clusters emerging from scRNA‐seq
studies is to manually localize the expression of cluster‐defining
genes using immunohistochemistry, immunofluorescence, or in
situ hybridization as discussed above. Methods have been
reported to aid in the determination of the minimal gene set
needed to spatially resolve a given set of cell clusters.(64)
However, this manual approach to spatial annotation is
dependent on the existence of suitable staining reagents and
can be infeasible to scale when large numbers of target genes
need to be stained to resolve the clusters detected. Although
methods have been reported to allow for arbitrary scaling of
RNA hybridization or in situ RNA sequencing‐based transcript
detection,(65–67) another approach is to perform transcriptional
profiling directly on histological sections. This approach has
been particularly developed for neuroscience research, in
which cell dissociation–based transcriptional profiling is
impractical. Here, we briefly mention two particular methods
introduced recently, spatial transcriptomics(68) and STARmap
(spatially resolved amplicon mapping).(69) The former method,
spatial transcriptomics, is the first approach to spatially resolve
RNA‐seq data in individual tissue sections. In this method,
spatially barcoded oligo(dT) primers are attached to the surface
of microscope slides, enabling a genomewide analysis. The
resolution of the original spatial transcriptomics approaches
were 30 µm; however, a more recently developed Slide‐seq
approach offers a 10 µm resolution, therefore making it feasible
to capture single cells in brain tissue.(70) The latter method,
STARmap, utilized an improved FISH (fluorescent in situ
hybridization) approach using SNAIL (specific amplification of
nucleic acid via intramolecular ligation) probes and hydrogels,
which can map somewhere between 160 and 1020 genes.
Another technique, MERFISH (multiplexed error‐robust FISH)
provides a similar ability to spatially measure gene expression
for approximately 100 to 1000 genes through the use multi-
plexed FISH probes whose barcodes are read out over
successive rounds of hybridization.(66) Although this number
of genes is sufficient to discover new clusters, this approach
can potentially hamper the discovery of new genes regulating
an important biological process, suggesting a role for
complementary approaches providing deep transcriptome
coverage, such as bulk RNA sequencing. Another important
limitation is that the resolution of current spatially resolved
approaches is approximately 10 to 30 µm; thus, it may capture
groups of adjoining cells, rather than single cells, especially in
regions of high cellular density such as in bone marrow or
periosteum. A scRNA‐seq approach fully integrating spatial
information of single cells could be particularly attractive to
correlate with strain maps or other spatially resolved mechan-
ical parameters during loading to generate an advanced
understanding of the transcriptional response to bone loading.
A challenge in applying these methodologies to bone is that
many skeletal cells are extremely compact and arranged in a
highly intricate manner. For example, in marrow space,
mesenchymal cells are intertwined with hematopoietic cells
and endothelial cells. Therefore, applicability of such spatial
transcriptional profiling approach will need to be determined
on a case‐by‐case basis. Lastly, all of these approaches for
spatial annotation require the production of high‐quality tissue
sections, and recently popularized methods for cutting and
transfer of unfixed, nondecalcified sections of adult bone can
help overcome hurdles in specimen preparation.(71)
Sample Insights From scRNA‐seq Studies in Bone
While most of the impact of scRNA‐seq studies on bone biology
will doubtless come from future studies, early examples of
scRNA‐seq studies in bone provide proof of the utility of this
approach. Chan and colleagues published key papers de-
scribing skeletal stem cells in young bones, first in mice termed
mouse skeletal stem cells (mSSCs)(72) and, more recently,
in humans termed human skeletal stem cells (hSSCs).(24) In
the first study, they identified nonhematopoietic/endothelial
AlphaV(CD51)+Thy1(CD90)‐CD105‐CD200+ cells isolated from
the perinatal growth plate as self‐renewing multipotent skeletal
stem cell populations, using extensive in vitro and transplanta-
tion assays. They also showed clonal cell populations within the
growth plate using multicolor lineage‐tracing experiments. In
this study, single‐cell sequencing was used to characterize
small numbers of these stem cells and their derivative
populations. In a second study, they conducted a scRNA‐seq
analysis of the microdissected human fetal growth plate and
found that cells in the late prehypertrophic zone and the
hypertrophic zone express human orthologs of mSSC‐specific
genes, therefore suggesting that hSSCs reside in these layers of
the growth plate.
There is a line of evidence that prehypertrophic and
hypertrophic chondrocytes represent transient cell types that
are destined to undergo apoptosis or transdifferentiate into
osteoblasts. In contrast, the resting zone of the growth plate has
been shown to contain stemlike cells, originally in rabbits based
on transplantation studies.(73) More recently, the existence of
skeletal stem cells within the resting zone has been demon-
strated based on more definitive lineage‐tracing experiments in
mice.(6) Cells in other layers of the growth plate, such as
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proliferating, prehypertrophic, and hypertrophic layers, do not
self‐renew and rapidly disappear from the growth plate.(6)
Potential fates of these non‐resting cells include apoptosis in the
hypertrophic layer and transdifferentiation into osteoblasts(74,75)
or bone marrow stromal cells,(76) as indicated by a series of
lineage‐tracing experiments in mice. In light of this literature,
more sophisticated approaches that can analyze and purify
these SSCs in their native environment are desirable. A recent
scRNA‐seq analysis of mouse neonatal growth plate discovered a
novel population of chondrocytes corresponding to borderline
chondrocytes, which was previously described by histological
analysis.(77) A follow‐up lineage‐tracing experiment further
demonstrated that these chondrocytes behave as transient
mesenchymal precursor cells. Thus, multiple groups have used
scRNA‐seq and other complementary techniques to uncover
cellular heterogeneity and discrete functionality of distinct
growth plate chondrocyte subpopulations.
Debnath and colleagues recently reported a novel popula-
tion of Cathepsin K (CTSK)‐labeled periosteal stem cells (PSCs).
Unlike the mesenchymal stem cells present in the endosteal
compartment, these PSCs do not express markers associated
with mesenchymal cells capable of supporting hematopoiesis,
such as LEPR or CD146, and can only mediate intramembra-
nous ossification at baseline.(78,79) Because the identification of
these cells was made through hypothesis‐driven FACS gating
and transplantation experiments, single‐cell analysis was
utilized as a parallel method to identify CTSK‐labeled stem
cell populations to see if this parallel approach converged on
nominating the same population as stem cells. CEL‐SEQ2 was
performed on mesenchymal CTSK+ periosteal cells, which
allowed for collecting the full surface immunophenotype for
each cell during index sorting and subsequently linking this
surface immunophenotype with that same cell’s RNA expres-
sion data. Analysis of CTSK‐cre‐labeled periosteal cells showed
clustering into four groups: group 1 was defined by expression
of Sox9 and Col2a1; group 2 expressed osteoblast markers such
as Bglap and Alpl; group 3 expressed Ly6a (Sca1); and a small
group 4 was characterized by high expression of alpha‐smooth
muscle actin (Acta2). Almost all of the cells identified as
periosteal stem cells on the basis of surface immunophenotype
fell into this group 1 expressing Sox9 and Col2a1. Why would
an intramembranous‐specialized stem cell express transcripts
classically associated with chondrocytes?(80) Previously, pulse‐
chase lineage tracing studies have identified both Sox9 and
Col2a1 was labeling long‐lived osteoblast progenitors in both
the endosteal and periosteal compartments.(76) Yamashiro and
colleagues also reported a set of periosteal cells in both long
bone and calvarium that display robust expression of Sox9.(81)
Similarly, ablation of the ability of Sox9‐expressing cells to give
rise to osteoblasts via deletion of osterix with Sox9‐cre resulted
in severe impairments in both intramembranous and endo-
chondral bone formation.(82,83) Thus, although Sox9 and Col2a1
are chondrocyte markers, they additionally serve as markers of
mesenchymal stem cells. In particular, their expression in both
intramembranous specialized periosteal stem cells and their
endochondral‐specialized endosteal counterparts suggests that
Sox9 and Col2a1 are core components of the transcriptional
signature shared by multiple populations of skeletal stem cells.
Group 2 within the pool of periosteal CTSK‐labeled cells was
defined by high expression of osteoblast markers such as Bglap
and Alpl, offering support for parallel immunohistochemical
and transplantation studies identifying that PSCs give rise to
osteoblasts. Further analysis of gene expression in this cluster
also identifies robust Ifitm5 expression, suggesting that Ifitm5
may have general utility in identifying osteoblasts in scRNA‐seq
studies.(84–86) Regarding the cluster of CTSK‐positive cells
expressing Acta2, it has been previously reported that Acta2
is a marker of pericytes and myofibroblasts that display
osteogenic capacity.(87,88) During fracture, periosteal mesench-
ymal cells labeled with an inducible Acta2‐cre undergo
expansion and can differentiate into osteogenic and chondro-
genic lineages.(88,89) Within the pool of CTSK cre‐labeled
periosteal mesenchyme, Acta2+ cells are distinct from FACS‐
defined PSCs, and PSCs sit at the apex of their differentiation
hierarchy in heterotopic transplantation studies.(3) Similarly, this
population of Acta2+ cells are distinct from the group 2 cells
expressing osteoblast markers. Taken together with prior
lineage tracing studies of Acta2+ cells, this suggests a model
whereby the CTSK‐lineage subset of Acta2+ cells are an
intermediate progenitor linking PSCs to mature osteoblasts,
and the transition of Acta2+ cells to osteoblasts may be
dynamically regulated in response to injury. However, further
direct transplantation studies will be needed to test this model
and establish the hierarchy of PSCs relative to Acta2+ cells.
This CEL‐SEQ2 study of CTSK‐labeled periosteal mesench-
ymal cells was further analyzed using Monocle to observe if the
cellular differentiation hierarchy computationally inferred from
cells directly isolated from the native bone environment was
consistent with the differentiation hierarchy experimentally
determined by heterotopic transplantation studies.(3) Unsuper-
vised analysis placed a vast majority of the CTSK‐lineage cells
along an unbranched linear differentiation trajectory. Consis-
tent with PSCs giving rise to THY1+ cells after transplantation,
FACS‐identified PSCs were present at the root of this trajectory
and the cells expressing later mesenchymal markers such as
THY1 and SCA1 were present at the end of the trajectory. Thus,
scRNA‐seq studies can provide insights into differentiation
hierarchy in minimally manipulated native systems that
complement the limitations of heterotopic transplantation
studies of defined populations.
Consistent with the above, analysis of genes that were
differentially expressed during this inferred differentiation trajec-
tory demonstrated the early expression and subsequent down-
regulation of markers associated with early mesenchymal
progenitors including Col2a1 and Sox9. Genes showing low early
expression and subsequent upregulation included the later‐stage
mesenchymal markers such as Thy1, Postn, CD34, and Ly6a
encoding SCA1. Interestingly, Bmp2 was noted very early in the
differentiation trajectory and was also detected in bulk sequencing
studies of PSCs. To put this into context, during earliest stages of
skeletal development, BMP signaling is necessary to initiate Sox9
expression and chondrogenesis in early limb bud mesenchymal
condensations, suggesting that BMP2 is a key inducer of skeletal
stem cells.(90) Consistent with this, BMP2 is able to expand skeletal
stem cells in vitro and induce skeletal stem cells de novo in soft
tissues,(72) and BMP2 is necessary for bone formation and to
initiate fracture healing.(91–93) Taken together with the expression
of BMP2 directly in skeletal stem cell populations in this data set,
this suggests that BMP2 may be involved in an autocrine loop to
maintain skeletal stem cell pools and that external signals tuning
BMP2 expression within skeletal stem cells may be critical
determinants of the size of this stem cell pool. This model is
consistent with a recent study finding that periosteal BMP2
controls functions specific to periosteal physiology, such as the
radial expansion of bone.(94) We speculate that this putative
autocrine model for stem cell self‐regulation may be advantageous
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in a system such as the skeleton that maintains separate pools of
stem cells in distinct anatomic compartments,(3) as it could
facilitate separate regulation of the sizes of each of these distinct
stem cell pools in a manner not possible with an externally
expressed systemic signal. The finding that endosteal bone
formation is relatively preserved with deletion of BMP2 despite
substantial periosteal defects suggests that these autocrine factors
regulating stem cell pool size or function are likely to be
“compartmentalized” with effects limited to specific subsets of
skeletal stem cells and, accordingly, specific anatomic regions
within bone.
Conclusions
Perhaps the key challenge in advancing our understanding of
the cellular basis of bone metabolism is “unmixing” the many
heterogeneous cell types present in bone to resolve discrete
homogenous populations. scRNA‐seq shows promise as an
important part of the experimental toolbox needed to address
this issue. However, tapping into this potential requires
extensive pre‐experimental planning to select specimens, cell
isolation methods, scRNA‐seq methods, and analysis tools
tailored to the experimental question. Even after completing a
scRNA‐seq study, post‐sequencing validation approaches are
needed to exclude that any key cell populations identified
represent analytic artifacts. Because each step along this path is
heavily informed by knowledge of the underlying biology,
bone biologists are best positioned to lead these advances, and
indeed a proliferation of accessible sequencing and analysis
tools make completion of scRNA‐seq studies accessible even
for groups with no specialized experience.
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